Vicarius Leadership Team – Executive Profiles

Head of Business Development

Professional Experience

Chief Business Officer, Genocea Biosciences, Cambridge, MA

VP of Corporate & Business Development, Idenix Pharmaceuticals, Cambridge, MA

Executive Director of IR & Corp. Communications, Idenix Pharmaceuticals, Cambridge, MA

Director of Corporate & Business Development, Biogen Idec, Cambridge, MA

Director of Investor Relations, Biogen Idec, Cambridge, MA

Biotechnology Equity Analyst, JPMorgan Securities, Boston, MA

Biotechnology Equity Associate, Bear Stearns International, London, UK

Postdoctoral Research Associate, Guy's Hospital, King’s College, London, UK

 

Key Achievements

Biotech Industry – Deal Making as Head of Business Development

  • Acquisition of Idenix by Merck, a $3.85B acquisition at ~240% premium, the highest premium to date for any health-care deal of >$100MM
  • Idenix/Janssen Phase 2 collaboration that enabled access to protease inhibitor for a key HCV combination clinical study to advance Idenix NS5A inhibitor
  • Idenix/Novartis collaboration renegotiation which included removal of option rights on all Idenix pipeline products from original agreement, enabling eventual acquisition by Merck
  • In-licensed adjuvant for Gencea’s personalized cancer vaccine program to enable on time start of key clinical trial

Biotech Industry – Investor Relations

  • Expanded sell side coverage and broadened institutional investor base at both Biogen and Idenix

Wall Street

  • Biotech coverage of nine US large caps, twelve US small/mid-caps and eight European companies
  • Closely involved with multiple successful biotech IPOs

Academic Immunology

  • Published seven peer reviewed manuscripts, two book chapters and three review articles

 

 

Education

Ph.D. in Immunobiology Program in Molecular, Cellular and Developmental Biology Department

Thesis topic: Early immune system development: alpha beta versus gamma delta T cell lineage commitment and cell cycle modulation

Yale University, New Haven, CT, USA

 

B.S. in Biology, cum laude

Thesis topic: Comparative immunology in marsupials

Trinity University, San Antonio, TX, USA

 

Nationality

USA

Languages

English, German

 

Other Executive Team

Member Profiles

  • President and CEO
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Head of Regulatory Affairs
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Post-Approval Regulatory Affairs
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Chief Compliance Officer
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Vice President, Market Access
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Head of Business Development,
  • Legal & External Affairs
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Chief Medical/Scientific Officer
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Chief Financial Officer
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Vice President,
  • Head of Commercial Strategy